RS51687B - Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain - Google Patents
Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic painInfo
- Publication number
- RS51687B RS51687B RS20110223A RSP20110223A RS51687B RS 51687 B RS51687 B RS 51687B RS 20110223 A RS20110223 A RS 20110223A RS P20110223 A RSP20110223 A RS P20110223A RS 51687 B RS51687 B RS 51687B
- Authority
- RS
- Serbia
- Prior art keywords
- phenyl
- methylphenylsulfanyl
- piperidine
- treatment
- neuropathic pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/12—Glutaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Jedinjenje koje je 4-[2-(4-metilfenil-sulfanil)fenil]piperidinHBr adiciona so u kristalnom obliku.Prijava sadrži još 14 patentnih zahteva.A compound which is a 4- [2- (4-methylphenyl-sulfanyl) phenyl] piperidineHBr addition salt in crystalline form. The application contains 14 more claims.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80500906P | 2006-06-16 | 2006-06-16 | |
DKPA200600816 | 2006-06-16 | ||
DKPA200700423 | 2007-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
RS51687B true RS51687B (en) | 2011-10-31 |
Family
ID=39722478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20110223A RS51687B (en) | 2006-06-16 | 2007-06-15 | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP2014098017A (en) |
KR (1) | KR101472595B1 (en) |
AR (1) | AR061480A1 (en) |
AT (1) | ATE508115T1 (en) |
BR (1) | BRPI0712758A2 (en) |
CA (1) | CA2784304A1 (en) |
DE (1) | DE602007014372D1 (en) |
DK (1) | DK2044020T3 (en) |
MY (1) | MY150698A (en) |
NZ (1) | NZ572856A (en) |
PT (1) | PT2044020E (en) |
RS (1) | RS51687B (en) |
SI (1) | SI2044020T1 (en) |
TN (1) | TNSN08461A1 (en) |
TW (1) | TWI444365B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101972931B1 (en) | 2017-10-19 | 2019-04-26 | 재단법인대구경북과학기술원 | Balloon type ecog measuring device and its manufacturing method |
CN116930385B (en) * | 2023-08-08 | 2024-02-20 | 北京爱思益普生物科技股份有限公司 | Method for measuring concentration of compound in high-salt-concentration preparation |
CN117305360A (en) * | 2023-09-15 | 2023-12-29 | 江南大学 | Mammalian cell nucleus transfection liquid, preparation method thereof and application thereof in cell nucleus delivery |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA81749C2 (en) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Derivated of phenylpiperazine as serotonin reuptake inhibitorS |
PL2044020T3 (en) * | 2006-06-16 | 2011-09-30 | H Lundbeck As | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
-
2007
- 2007-06-15 CA CA2784304A patent/CA2784304A1/en not_active Abandoned
- 2007-06-15 BR BRPI0712758-8A patent/BRPI0712758A2/en not_active IP Right Cessation
- 2007-06-15 PT PT07764496T patent/PT2044020E/en unknown
- 2007-06-15 NZ NZ572856A patent/NZ572856A/en not_active IP Right Cessation
- 2007-06-15 SI SI200730594T patent/SI2044020T1/en unknown
- 2007-06-15 AR ARP070102640A patent/AR061480A1/en unknown
- 2007-06-15 DE DE602007014372T patent/DE602007014372D1/en active Active
- 2007-06-15 MY MYPI20084894 patent/MY150698A/en unknown
- 2007-06-15 AT AT07764496T patent/ATE508115T1/en active
- 2007-06-15 DK DK07764496.1T patent/DK2044020T3/en active
- 2007-06-15 RS RS20110223A patent/RS51687B/en unknown
- 2007-06-20 TW TW096121999A patent/TWI444365B/en not_active IP Right Cessation
-
2008
- 2008-11-17 TN TNP2008000461A patent/TNSN08461A1/en unknown
- 2008-12-11 KR KR1020087030260A patent/KR101472595B1/en not_active IP Right Cessation
-
2014
- 2014-02-03 JP JP2014018411A patent/JP2014098017A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR101472595B1 (en) | 2014-12-15 |
TNSN08461A1 (en) | 2010-04-14 |
TWI444365B (en) | 2014-07-11 |
CA2784304A1 (en) | 2007-12-21 |
AR061480A1 (en) | 2008-08-27 |
MY150698A (en) | 2014-02-28 |
ATE508115T1 (en) | 2011-05-15 |
NZ572856A (en) | 2012-02-24 |
TW200817329A (en) | 2008-04-16 |
SI2044020T1 (en) | 2011-06-30 |
PT2044020E (en) | 2011-05-12 |
DK2044020T3 (en) | 2011-08-15 |
KR20090018630A (en) | 2009-02-20 |
BRPI0712758A2 (en) | 2012-09-25 |
DE602007014372D1 (en) | 2011-06-16 |
JP2014098017A (en) | 2014-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090250L (en) | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
NZ592543A (en) | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | |
CL2007002930A1 (en) | A COMPOUND 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROFENOXI] -N-METHYLPIRIDIN-2-CARBONXAMIDE MONOHIDRATADO; PREPARATION PROCESS; COMPOSITION AND PHARMACEUTICAL COMBINATION; AND USE FOR THE TREATMENT OF HYPERPROLIFERATI DISORDERS | |
CY1112345T1 (en) | Polymorphic Form of 4- [3- (4-Cyclopropanecarbonyl-Piperazine-1-Carbonyl) -4-Fluoro-Benzyl] -2H-Phthalazin-1-One | |
DK2044043T4 (en) | 1- [2- (2,4-DIMETHYLPHENYL SULFANYL) -PHENYL] PIPERAZINE HYDROBROMID AS A COMPOUND WITH COMBINED SEROTONING INSULATION, 5-HT3 AND 5-HT1A ACTIVITY FOR TREATMENT OF KOGN | |
WO2008113360A3 (en) | 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression | |
SMAP200900055A (en) | Chinazolines for the inhibition of pdk1 | |
SMAP200800059A (en) | Chinazolines for the inhibition of pdk1 | |
NZ592224A (en) | Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition | |
EA201000545A1 (en) | COMPOSITION OF CYBENTENTAN, CONTAINING MANNITE AND / OR MICROCRYSTAL PULSIS | |
ECSP10010145A (en) | USE OF 3,11B-CIS-DIHIDROTETRABENAZINE IN THE TREATMENT OF MULTIPLE SCLEROSIS AND SELF-IMMUNE HONEY MIELITIS | |
RS51687B (en) | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
MX2010012421A (en) | 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethyl amino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinam ide as nk1 receptor antagonists. | |
BRPI0816221A2 (en) | Crystalline Form 1 of 2 - ((r) -2-methylpyrrolidin-2-ol) -1h-benzimidazol-4-carboxamide | |
EA201171230A1 (en) | SEROTONIN AND NOREPINEFRINE RETURN CAPTURE INHIBITOR | |
HK1140949A1 (en) | Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl) phenyl]piperidine 4-[2-(4-)-] | |
EA201070737A1 (en) | THERAPEUTIC APPLICATION OF COMPOUNDS WITH AFFINITY TO SEROTONIN TRANSFER, SEROTONIN RECEPTORS AND NORADRENALINE TRANSFER | |
UA95801C2 (en) | Crystalline forms of 4-[2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
EA201000611A1 (en) | 4,4-DESIGNED PIPERIDINES | |
TH110866A (en) | N-hydroxy salt -3- [4 - [[[2- (2-methyl-1H-indol-3-il) ethyl] amino] methyl] Phenyl] -2E-2-propinamide |